Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Hu Y, Huang C, Sun Y, et al. Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol. 2016;34(12):1350–7.

Article  PubMed  Google Scholar 

Huscher CG, Mingoli A, Sgarzini G, et al. Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg. 2004;241(2):232–7.

Article  Google Scholar 

Viñuela EF, Gonen M, Brennan MF, et al. Laparoscopic versus open distal gastrectomy for gastric cancer: a meta-analysis of randomized controlled trials and high-quality nonrandomized studies. Ann Surg. 2012;255(3):446–56.

Article  PubMed  Google Scholar 

Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report–a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg. 2010;251(3):417–20.

Article  PubMed  Google Scholar 

D’Angelica M, Gonen M, Brennan MF, et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg. 2004;240(5):808–16.

Article  PubMed  PubMed Central  Google Scholar 

Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345(10):725–30.

Article  CAS  PubMed  Google Scholar 

Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11–20.

Article  CAS  PubMed  Google Scholar 

Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol. 2011;29(13):1715–21.

Article  CAS  PubMed  Google Scholar 

Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.

Article  CAS  PubMed  Google Scholar 

Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29(33):4387–93.

Article  CAS  PubMed  Google Scholar 

Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315–21.

Article  CAS  PubMed  Google Scholar 

Lima IS, Yasui Y, Scarfe A, et al. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta. Canada Cancer. 2011;117(16):3833–40.

Article  PubMed  Google Scholar 

Des Guetz G, Nicolas P, Perret GY, et al. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer. 2010;46(6):1049–55.

Article  PubMed  Google Scholar 

Alkis N, Durnali AG, Arslan UY, et al. Optimal timing of adjuvant treatment in patients with early breast cancer. Med Oncol. 2011;28(4):1255–9.

Article  CAS  PubMed  Google Scholar 

Lohrisch C, Paltiel C, Gelmon K, et al. Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer. J Clin Oncol. 2006;24(30):4888–94.

Article  PubMed  Google Scholar 

Murakami Y, Uemura K, Sudo T, et al. Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection. Cancer Chemother Pharmacol. 2013;71(2):419–29.

Article  CAS  PubMed  Google Scholar 

Biagi JJ, Raphael MJ, Mackillop WJ, et al. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011;305(22):2335–42.

Article  CAS  PubMed  Google Scholar 

Gagliato Dde M, Gonzalez-Angulo AM, Lei X, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014;32(8):735–44.

Article  PubMed  Google Scholar 

Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107(11):2581–8.

Article  PubMed  Google Scholar 

Nitti D, Wils J, Dos Santos JG, et al. Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. Ann Oncol. 2006;17(2):262–9.

Article  CAS  PubMed  Google Scholar 

Bajetta E, Buzzoni R, Mariani L, et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group. Ann Oncol. 2002;13(2):299–307.

Article  CAS  PubMed  Google Scholar 

Nakajima T, Kinoshita T, Nashimoto A, et al. Randomized controlled trial of adjuvant uracil-tegafur versus surgery alone for serosa-negative, locally advanced gastric cancer. Br J Surg. 2007;94(12):1468–76.

Article  CAS  PubMed  Google Scholar 

Zheng CH, Lu J, Zheng HL, et al. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: a phase 3 randomized controlled trial. Surgery. 2018;163(2):300–4.

Article  PubMed  Google Scholar 

Lin JX, Lin JP, Wang ZK, et al. Assessment of laparoscopic spleen-preserving hilar lymphadenectomy for advanced proximal gastric cancer without invasion into the greater curvature: a randomized clinical trial. JAMA Surg. 2023;158(1):10–8.

Article  PubMed  Google Scholar 

Zheng C, Xu Y, Zhao G, et al. Outcomes of laparoscopic total gastrectomy combined with spleen-preserving hilar lymphadenectomy for locally advanced proximal gastric cancer: a nonrandomized clinical trial. JAMA Netw Open. 2021;4(12): e2139992.

Article  PubMed  PubMed Central  Google Scholar 

Chen QY, Liu ZY, Zhong Q, et al. Clinical impact of delayed initiation of adjuvant chemotherapy among patients with stage II/III gastric cancer: can we do better? Front Oncol. 2020;10:1149.

Article  PubMed  PubMed Central  Google Scholar 

Ganju J, Yu X, Ma GJ. Robust inference from multiple test statistics via permutations: a better alternative to the single test statistic approach for randomized trials. Pharm Stat. 2013;12(5):282–90.

Article  PubMed  Google Scholar 

Lin Y, Zhou K, Ganju J. A single test for rejecting the null hypothesis in subgroups and in the overall sample. J Biopharm Stat. 2017;27(1):101–10.

Article  PubMed  Google Scholar 

Groot VP, Gemenetzis G, Blair AB, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(6):1154–62.

Article  PubMed  Google Scholar 

Koizumi W, Takiuchi H, Yamada Y, et al. Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study). Ann Oncol. 2010;21(5):1001–5.

Article  CAS  PubMed  Google Scholar 

De Vita F, Orditura M, Matano E, et al. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer. 2005;92(9):1644–9.

Article  PubMed  PubMed Central  Google Scholar 

Fine JPGR. A proportional hazards mode